Leslie Shaw to Enzyme Inhibitors
This is a "connection" page, showing publications Leslie Shaw has written about Enzyme Inhibitors.
Connection Strength
0.462
-
Kaplan B, Meier-Kriesche HU, Friedman G, Mulgaonkar S, Gruber S, Korecka M, Brayman KL, Shaw LM. The effect of renal insufficiency on mycophenolic acid protein binding. J Clin Pharmacol. 1999 Jul; 39(7):715-20.
Score: 0.139
-
Nowak I, Wu J, Brayman KL, Shaw LM. Is the glucuronide metabolite of MPA pharmacologically active? Transplant Proc. 1997 Feb-Mar; 29(1-2):337.
Score: 0.118
-
Shaw LM, Sollinger HW, Halloran P, Morris RE, Yatscoff RW, Ransom J, Tsina I, Keown P, Holt DW, Lieberman R, et al. Mycophenolate mofetil: a report of the consensus panel. Ther Drug Monit. 1995 Dec; 17(6):690-9.
Score: 0.109
-
Brandhorst G, Marquet P, Shaw LM, Liebisch G, Schmitz G, Coffing MJ, Domke I, Streit F, Luthe H, Oellerich M. Multicenter evaluation of a new inosine monophosphate dehydrogenase inhibition assay for quantification of total mycophenolic acid in plasma. Ther Drug Monit. 2008 Aug; 30(4):428-33.
Score: 0.065
-
Shaw LM, Rabinovitz I, Wang HH, Toker A, Mercurio AM. Activation of phosphoinositide 3-OH kinase by the alpha6beta4 integrin promotes carcinoma invasion. Cell. 1997 Dec 26; 91(7):949-60.
Score: 0.031